Article
Absence of somatic changes in p21 gene in non-Hodgkin's lymphoma and chronic myelogenous leukemia.
Hematologic pathology - 1 Jan 1995
Gong J Z, Zhou H, Hu Z, Schulman P, Vinceguerra V, Broome J D, Koduru P
Abstract excerpt
p21 is induced by and mediates the effects of p53 in response to DNA damage arresting the cell in G1 or G2, by inhibiting multiple cyclin-cyclin-dependent kinases (CDK) or binding to proliferating-cell nuclear antigen (PCNA), respectively. To determine whether p21 mutants occur in tumors we examined DNA from 188 primary non-Hodgkin's B-cell lymphoma (NHL) tumors and 84 chronic myelogenous leukemia samples for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
